NEW YORK, Aug. 7 – Genomica Corporation's revenue jumped 17 percent to $464,000 for the second quarter 2001, compared to $396,000 recorded in the year-ago period, the company said on Tuesday.

The Boulder, Colo.-based company attributed the revenue rise to licensing fees from its LinkMapper software and consulting fees from its alliance with Applied Biosystems.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.